Secondary osteoporosis

PR Ebeling, HH Nguyen, J Aleksova… - Endocrine …, 2022 - academic.oup.com
Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

[HTML][HTML] Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and …

UJ Jung, MS Choi - International journal of molecular sciences, 2014 - mdpi.com
Accumulating evidence indicates that obesity is closely associated with an increased risk of
metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and …

[HTML][HTML] Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation

J Yang, M Fernández-Galilea, L Martínez-Fernández… - Nutrients, 2019 - mdpi.com
Aging is a complex phenomenon characterized by the progressive loss of tissue and organ
function. The oxidative-stress theory of aging postulates that age-associated functional …

[HTML][HTML] Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease

S Stojsavljević, MG Palčić, LV Jukić… - World journal of …, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in
the liver of a patient with no history of alcohol abuse or other causes for secondary hepatic …

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee

P Vajro, S Lenta, P Socha, A Dhawan… - Journal of pediatric …, 2012 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in children and adolescents in the United States, and most probably also in the rest of the …

[PDF][PDF] Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

AE Feldstein, A Wieckowska, AR Lopez, YC Liu… - …, 2009 - Wiley Online Library
Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH).
We have recently demonstrated that plasma cytokeratin 18 (CK‐18) fragment levels …

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

H Tilg, AR Moschen - Trends in Endocrinology & Metabolism, 2008 - cell.com
Non-alcoholic fatty liver disease (NAFLD), the major cause of abnormal liver function in the
western world, is often associated with obesity and diabetes. In obese individuals, fat …

[HTML][HTML] Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic

K Hassan, V Bhalla, ME El Regal… - World journal of …, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is quickly becoming one of the most prominent
causes of liver disease worldwide. The increasing incidence of NAFLD is tied to the obesity …

Leptin in nonalcoholic fatty liver disease: a narrative review

SA Polyzos, J Kountouras, CS Mantzoros - Metabolism, 2015 - Elsevier
Leptin, the first described adipokine, interplays with hepatic metabolism. The aim of this
review was to summarize available data on the association between leptin and nonalcoholic …

[HTML][HTML] An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic …

YJ Yang, DJ Kim - International journal of molecular sciences, 2021 - mdpi.com
The prevalence of osteoporosis and sarcopenia is significantly higher in patients with liver
disease than in those without liver disease and osteoporosis and sarcopenia negatively …